Pharmacological strategies for preventing post-stroke seizures and epilepsy.

Front Neurol · 2025 · PMC12823330 · PMID 41586111

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a nonsignificant trendp = 0.08so close (0.05 < p ≤ 0.1)

A randomised control trial comparing the effects of levetiracetam (titrated up to 500 mg twice daily) and carbamazepine (titrated up to 300 mg twice daily) in 128 patients with LPSS demonstrated a nonsignificant trend towards a higher seizure-free ratio for patients taking levetiracetam (94% vs. 85%, p = 0.08) ( 63 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.